Semorex, Inc.

Fanwood, NJ 07023
http://www.semorex.com
8 Employees

SBIR Award Summary

Total Number of Awards 4
Total Value of Awards $1.05MM
First Award Date 05/16/02
Most Recent Award Date 04/01/08

Key Personnel

Last Name Name Awards Contact
Green Bernard S Green 4 Message

4 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-07-80
Budget: 04/01/08 - 09/30/09

DESCRIPTION (provided by applicant): Systemic fungal infection (SFI) is a life threatening disease affecting growing numbers of immunocompromised and other patients. The current "gold standard" diagnostic method for SFI culturing of affected tissue or blood requires days to weeks and fails in over half of the tests. Diagnostic alternatives on ...

Phase 1 SBIR

Agency: Chemical and Biological Defense Program
Topic: CBD06-104
Budget: 05/18/06 - 11/17/06

Chemical weapon nerve agents (CWNAs) are extremely deadly substances, and as a key element in the arsenals of rogue nations and terrorists who are willing to use them, they represent a constant threat to our military and civilian personnel. Current methods for detecting CWNA exposure in individuals have many deficiencies, including excessive fa...

Phase 2 SBIR

Agency: Chemical and Biological Defense Program
Topic: C02-106
Budget: 04/07/03 - 04/07/05

Semorex has carried out a successful Phase I project which demonstrates the potential of Molecularly Imprinted Polymer (MIP) technology to solve the critical problem of improving organophosphate (OP) detection. MIPs, plastic polymers with specific molecular binding sites molded into them, combine the selectivity of antibodies with the robustnes...

Phase 1 SBIR

Agency: Chemical and Biological Defense Program
Topic: CBD02-106
Budget: 05/16/02 - 04/07/05

Molecularly Imprinted Polymers (MIPs), substances having selective binding sites molded into the polymers, combine the selectivity of antibodies with the robustness of polymers. Recent advances by Semorex provide MIPs having affinity binding constants equal to or better than those of antibodies. This enhanced capability allows us to prepare MIPs...